Article
KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma.
Tissue antigens - 1 Apr 2007
Pellett F, Siannis F, Vukin I, Lee P, Urowitz M B, Gladman D D
Abstract excerpt
We investigated killer immunoglobulin-like receptors (KIRs) and the human leukocyte antigen (HLA)-C ligands for the corresponding inhibitory KIRs in Caucasian patients, 304 with systemic lupus erythematosus (SLE) and 90 with scleroderma [or progressive systemic sclerosis (PSS)] compared with 416 Caucasian controls. Compared with controls, KIR2DS1 in the absence of KIR2DS2 was increased in both SLE (P= 0.04) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
